Convalescent COVID-19 patients showed strong anti–SARS-CoV-2 S protein–specific B cell responses and developed memory and antibody-producing B cells that may have participated in the control of infection and the establishment of humoral immunity. This evidence concerns the gene PROS1 and COVID-19.